These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36976637)

  • 41. Myeloid cell-synthesized coagulation factor X dampens antitumor immunity.
    Graf C; Wilgenbus P; Pagel S; Pott J; Marini F; Reyda S; Kitano M; Macher-Göppinger S; Weiler H; Ruf W
    Sci Immunol; 2019 Sep; 4(39):. PubMed ID: 31541031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A NAG-Guided Nano-Delivery System for Redox- and pH-Triggered Intracellularly Sequential Drug Release in Cancer Cells.
    Liang Y; Zhang J; Tian B; Wu Z; Svirskis D; Han J
    Int J Nanomedicine; 2020; 15():841-855. PubMed ID: 32103941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding.
    Roblek M; Strutzmann E; Zankl C; Adage T; Heikenwalder M; Atlic A; Weis R; Kungl A; Borsig L
    Neoplasia; 2016 Jan; 18(1):49-59. PubMed ID: 26806351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
    J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.
    Sanford DE; Belt BA; Panni RZ; Mayer A; Deshpande AD; Carpenter D; Mitchem JB; Plambeck-Suess SM; Worley LA; Goetz BD; Wang-Gillam A; Eberlein TJ; Denardo DG; Goedegebuure SP; Linehan DC
    Clin Cancer Res; 2013 Jul; 19(13):3404-15. PubMed ID: 23653148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IRAK-M Regulates Monocyte Trafficking to the Lungs in Response to Bleomycin Challenge.
    Reader BF; Sethuraman S; Hay BR; Thomas Becket RV; Karpurapu M; Chung S; Lee YG; Christman JW; Ballinger MN
    J Immunol; 2020 May; 204(10):2661-2670. PubMed ID: 32253243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis.
    Pattarawat P; Hunt JT; Poloway J; Archibald CJ; Wang HR
    Cancer Chemother Pharmacol; 2021 Sep; 88(3):415-425. PubMed ID: 34043046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inducing trained immunity in pro-metastatic macrophages to control tumor metastasis.
    Ding C; Shrestha R; Zhu X; Geller AE; Wu S; Woeste MR; Li W; Wang H; Yuan F; Xu R; Chariker JH; Hu X; Li H; Tieri D; Zhang HG; Rouchka EC; Mitchell R; Siskind LJ; Zhang X; Xu XG; McMasters KM; Yu Y; Yan J
    Nat Immunol; 2023 Feb; 24(2):239-254. PubMed ID: 36604547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy.
    Ye X; Xie G; Liu Z; Tang J; Cui M; Wang C; Guo C; Tang J
    Med Sci Monit; 2020 Sep; 26():e922703. PubMed ID: 32946432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer.
    Takeda Y; Wada T; Nishitani Y; Matsumoto M; Hojo K; Maekawa R; Yoshioka T
    Cancer Lett; 2002 Aug; 182(1):61-8. PubMed ID: 12175524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversal of aging-associated increase in myelopoiesis and expression of alarmins by angiotensin-(1-7).
    Chittimalli K; Jahan J; Sakamuri A; Weyrick H; Winkle W; Adkins S; Vetter SW; Jarajapu YPR
    Sci Rep; 2023 Feb; 13(1):2543. PubMed ID: 36782016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].
    Tang CH; Liu XQ; Yang SF; Zhu B; Gao HJ
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):808-12. PubMed ID: 19173823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced anti-tumor efficiency of gemcitabine prodrug by FAPα-mediated activation.
    Sun J; Yang D; Cui SH; Zhang HT; Fu Y; Wang JC; Zhang Q
    Int J Pharm; 2019 Mar; 559():48-57. PubMed ID: 30677483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.
    Hartwig T; Montinaro A; von Karstedt S; Sevko A; Surinova S; Chakravarthy A; Taraborrelli L; Draber P; Lafont E; Arce Vargas F; El-Bahrawy MA; Quezada SA; Walczak H
    Mol Cell; 2017 Feb; 65(4):730-742.e5. PubMed ID: 28212753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
    Zhang R; Ru Y; Gao Y; Li J; Mao S
    Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer.
    Li YJ; Wu JY; Wang JM; Hu XB; Cai JX; Xiang DX
    Acta Biomater; 2020 Jan; 101():519-530. PubMed ID: 31629893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X.
    Tai SJ; Herzog RW; Margaritis P; Arruda VR; Chu K; Golden JA; Labosky PA; High KA
    J Thromb Haemost; 2008 Feb; 6(2):339-45. PubMed ID: 18036190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.
    Vandereyken M; Jacques S; Van Overmeire E; Amand M; Rocks N; Delierneux C; Singh P; Singh M; Ghuysen C; Wathieu C; Zurashvili T; Sounni NE; Moutschen M; Gilles C; Oury C; Cataldo D; Van Ginderachter JA; Rahmouni S
    PLoS One; 2017; 12(10):e0185786. PubMed ID: 29020102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.
    Bessler WK; Kim G; Hudson FZ; Mund JA; Mali R; Menon K; Kapur R; Clapp DW; Ingram DA; Stansfield BK
    Hum Mol Genet; 2016 Mar; 25(6):1129-39. PubMed ID: 26740548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.